- ►umich.edu [PDF] ASF Lok - The New England Journal of Medicine, 2002 - nejm.highwire.org Insulin in the dose and regimen used in this study neither delayed nor prevented
type 1 diabetes in high-risk persons. ... Monoclonal Antibody in New-Onset Type
1 Diabetes Mellitus Mechanisms that destroy beta cells in type 1 diabetes ... Cited by 1855 - Related articles - BL Direct - All 35 versions
D Lavanchy - Journal of Viral hepatitis, 2004 - medscape.com World Health Organization. Hepatitis B. World Health Organization Fact Sheet 204
(Revised October 2000). WHO Web site. 2000. http://who.int/inf-fs/en/fact204.
html. ... Liaw YF, Leung NW, Chang TT et al. Effects of extended ... Cited by 537 - Related articles - BL Direct - All 7 versions
UH Iloeje, HI Yang, J Su, CL Jen, SL You, CJ … - Gastroenterology, 2006 - Elsevier Background & Aims: Cirrhosis develops as a result of hepatic inflammation and
subsequent fibrosis in chronic hepatitis B infection. We report on the
relationship between hepatitis B viremia and progression to cirrhosis in ... Cited by 382 - Related articles - All 3 versions
EE Mast, HS Margolis, AE Fiore, EW Brink, ST … - MMWR, 2005 - cdc.gov The material in this report originated in the National Center for HIV/AIDS,
Viral Hepatitis, STD, and TB Prevention (proposed), Kevin A. Fenton, MD, PhD,
Director; the Division of Viral Hepatitis, John W. Ward, MD, Director; the ... Cited by 206 - Related articles - Cached - All 7 versions
- ►bmj.com HLY Chan, AY Hui, ML Wong, AML Tse, LCT … - British Medical Journal, 2004 - gut.bmj.com Results: In total, 426 patients were followed up for 1664 person years; median
225 (range 12–295) weeks. Forty nine (11%) patients had underlying clinical
liver cirrhosis. A total of 242 (57%) and 179 (42%) patients had HBV ... Cited by 174 - Related articles - BL Direct - All 7 versions
H Mommeja-Marin, E Mondou, MR Blum, F … - Hepatology, 2003 - interscience.wiley.com Currently, compounds under evaluation for treatment of chronic hepatitis B virus
(HBV) infection are evaluated with liver histology as the primary end point for
efficacy. However, because of practical limitations in serial liver ... Cited by 168 - Related articles - All 3 versions
- ►umich.edu [PDF] HJ Yim, ASF Lok - Hepatology, 2006 - deepblue.lib.umich.edu Remarkable progress has been made in our understanding of the natural history of
chronic hepatitis B virus (HBV) infection in the past 25 years. Availability of
sensitive HBV DNA assays and application of sophisticated immunological ... Cited by 149 - Related articles - View as HTML - BL Direct - All 5 versions
- ►bmj.com [PDF] MF Yuen, HJ Yuan, DKH Wong, JCH Yuen, … - British Medical Journal, 2005 - gut.bmj.com Online First articles must include the digital object identifier (DOIs) and date
of initial publication. establish publication priority; they are indexed by
PubMed from initial publication. Citations to may be posted when available ... Cited by 132 - Related articles - All 11 versions
- ►angrylapdog.com CW Shepard, EP Simard, L Finelli, AE Fiore, … - Epidemiologic reviews, 2006 - epirev.oxfordjournals.org.p.angrylapdog.com Worldwide, two billion people have been infected with hepatitis B virus (HBV),
360 million have chronic infection, and 600,000 die each year from HBV-related
liver disease or hepatocellular carcinoma. This comprehensive review of ... Cited by 124 - Related articles - BL Direct - All 7 versions
- ►ucsf.edu [PDF] EB Keeffe, S Zeuzem, RS Koff, DT Dieterich, R … - Clinical Gastroenterology and Hepatology, 2007 - Elsevier An international group of experienced hepatologists and virologists conducted a
single-day workshop to review the management of patients with chronic hepatitis
B receiving treatment with oral nucleosides or nucleotides. Guidelines ... Cited by 121 - Related articles - All 13 versions
